Take Control of Your Lung Cancer Journey with Precision Genetic Testing
Receiving a lung cancer diagnosis can feel overwhelming, but understanding your cancer’s specific genetic makeup provides the clarity and direction you need. Our comprehensive Lung Cancer Genetic Panel gives you and your medical team the precise information required to choose the most effective targeted treatments for your unique situation.
Understanding Your Lung Cancer Genetic Profile
This advanced genetic panel analyses four critical biomarkers that determine how your lung cancer will respond to specific targeted therapies:
- EGFR (Epidermal Growth Factor Receptor): Mutations in this gene can make your cancer highly responsive to EGFR inhibitor medications
- ALK1 (Anaplastic Lymphoma Kinase): Rearrangements in this gene indicate excellent response to ALK inhibitors
- ROS1: Gene fusions that respond well to targeted ROS1 inhibitors
- MET: Amplifications or mutations that may benefit from MET-targeted treatments
Using sophisticated FISH and Sanger Sequencing methods, we provide your oncology team with the detailed genetic blueprint needed to personalise your treatment approach.
Who Should Consider This Genetic Testing?
This testing is particularly important if you:
- Have been recently diagnosed with non-small cell lung cancer (NSCLC)
- Are considering targeted therapy options beyond standard chemotherapy
- Want to understand why previous treatments may not have been effective
- Have a family history of lung cancer or genetic predisposition
- Are seeking the most personalised treatment approach available
- Want to explore clinical trial eligibility based on genetic markers
Early genetic testing can significantly impact your treatment success and quality of life.
Why Genetic Testing Matters for Your Health Journey
- Personalised Treatment: Match your cancer with the most effective targeted therapies
- Avoid Ineffective Treatments: Prevent unnecessary side effects from medications that won’t work for your specific cancer type
- Improved Outcomes: Targeted therapies often provide better results with fewer side effects
- Peace of Mind: Know you’re pursuing the most scientifically advanced treatment options
- Clinical Trial Access: Genetic information may open doors to cutting-edge treatment trials
Understanding Your Test Results
Your results will clearly indicate which biomarkers are present in your cancer cells, providing your medical team with:
- Specific genetic mutations or rearrangements detected
- Recommended targeted therapy options
- Clear interpretation of what each finding means for your treatment
- Guidance on next steps in your cancer care journey
Our medical team is available to help you and your doctor understand the results and their implications for your treatment plan.
Investment in Your Health Journey
| Service | Regular Price | Special Price | Turnaround Time |
|---|---|---|---|
| Lung Cancer Genetic Panel (EGFR, ALK1, ROS1, MET) | R10,000 | 5-7 days |
Note: This testing requires a doctor’s prescription and is performed on tumour tissue samples. Prescription requirements do not apply for surgery, pregnancy cases, or international travel planning.
Why Trust Oracle Genomics?
- Nationwide Coverage: Accessible testing centres in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Medical Expertise: Advanced testing performed by experienced oncology specialists
- Accuracy Guarantee: State-of-the-art FISH and Sanger Sequencing methods ensure reliable results
- Patient-Focused Care: We understand the emotional journey of cancer diagnosis and provide compassionate support
- Rapid Results: Receive your comprehensive genetic profile within 5-7 days
Take the Next Step in Your Cancer Care
Don’t leave your treatment decisions to chance. Get the precise genetic information needed to fight your lung cancer effectively.
Limited Time Offer: Save R3,350 on this comprehensive genetic panel. Book today to secure your special pricing.
Available at our centres in Johannesburg, Cape Town, Durban, Pretoria and nationwide. Your journey to personalised cancer care starts here.
